Story · Medicine & Biotech
In-Silico Design, QSAR Modeling, Molecular Docking, MD Simulation, Pharmacokinetic and ADMET Studies of 3-Cyanopyridine Derivatives as Potential Anti-Breast Cancer Agents
1 outlet · first reported by Research Square 15h ago
Coverage, in order
-
15h agoIn-Silico Design, QSAR Modeling, Molecular Docking, MD Simulation, Pharmacokinetic and ADMET Studies of 3-Cyanopyridine Derivatives as Potential Anti-Breast Cancer Agents
Background Breast cancer remains a major global health challenge, creating a need for new compounds with improved antiproliferative activity and drug-like properties. This study investigated 3-cyanopyridine derivatives with reported activity against the MCF-7 breast cancer cell line and explored…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.